|
Alzheimer's disease
Citations 271-280 of 578 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
High total cholesterol levels in late life associated with a reduced risk of dementia
- M. M. Mielke, P. P. Zandi, M. Sjögren, D. Gustafson, S. Östling, B. Steen, and I. Skoog
Neurology 2005; 64: 1689-1695.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Motor signs predict poor outcomes in Alzheimer disease
- N. Scarmeas, M. Albert, J. Brandt, D. Blacker, G. Hadjigeorgiou, A. Papadimitriou, B. Dubois, M. Sarazin, D. Wegesin, K. Marder, K. Bell, L. Honig, and Y. Stern
Neurology 2005; 64: 1696-1703.
[Abstract]
[Full text]
[PDF]
- ARTICLES
The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment
- J.H.T. Karlawish, D. J. Casarett, B. D. James, S. X. Xie, and S. Y.H. Kim
Neurology 2005; 64: 1514-1519.
[Abstract]
[Full text]
[PDF]
- ARTICLES
MRI predictors of risk of incident Alzheimer disease: A longitudinal study
- T. R. Stoub, M. Bulgakova, S. Leurgans, D. A. Bennett, D. Fleischman, D. A. Turner, and L. deToledo-Morrell
Neurology 2005; 64: 1520-1524.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Incidence and etiology of dementia in a large elderly Italian population
- G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Dalmonte, M. Bianchin, and E. Mariani
Neurology 2005; 64: 1525-1530.
[Abstract]
[Full text]
[PDF]
- ARTICLES
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study
- C. Dufouil, F. Richard, N. Fiévet, J. F. Dartigues, K. Ritchie, C. Tzourio, P. Amouyel, and A. Alpérovitch
Neurology 2005; 64: 1531-1538.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Classification of vascular dementia in the Cardiovascular Health Study Cognition Study
- O. L. Lopez, L. H. Kuller, J. T. Becker, W. J. Jagust, S. T. DeKosky, A. Fitzpatrick, J. Breitner, C. Lyketsos, C. Kawas, and M. Carlson
Neurology 2005; 64: 1539-1547.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Clinical effects of Aß immunization (AN1792) in patients with AD in an interrupted trial
- S. Gilman, M. Koller, R. S. Black, L. Jenkins, S. G. Griffith, N. C. Fox, L. Eisner, L. Kirby, M. Boada Rovira, F. Forette, J. -M. Orgogozo for the AN1792(QS-21)-201 Study Team
Neurology 2005; 64: 1553-1562.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Effects of Aß immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
- N. C. Fox, R. S. Black, S. Gilman, M. N. Rossor, S. G. Griffith, L. Jenkins, M. Koller for the AN1792(QS-21)-201 Study Team
Neurology 2005; 64: 1563-1572.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Screening for neurofilament inclusion disease using  -internexin immunohistochemistry
- Hirotake Uchikado, Gerry Shaw, Deng-Shun Wang, and Dennis W. Dickson
Neurology 2005; 64: 1658-1659.
[Full text]
[PDF]
|
|
